These results indicated that MRP8/14 induced Ip-10 mRNA expression in the late stage of endotoxemia by activating the IFNβ-JAK1/TYK2-STAT1-IRF7 signaling pathway. The gene discussed is CXCL10; the disease is serum lipopolysaccharide activity.